Hydrogen Inhalation Boosts Lung Treatment for Silicosis Patients
- Authors
- Kang Xiao, Yanping Sang, Mao Cao, Yong Yang, Mengjie Cheng, Jiazi Ma, Siqi Wang, Xinyue Li, Xuansheng Ding, Zhongjun Du
- Journal
- Respiratory Medicine
- Year
- 2026
- DOI
- 10.1016/j.rmed.2026.108939
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Silicosis
- Body System
- Respiratory
TL;DR
In patients with stage II silicosis, hydrogen inhalation plus tetrandrine improved lung gas-exchange capacity, lowered IL-6, and eased symptoms more than tetrandrine alone.
Key Finding
Patients who received hydrogen gas combined with tetrandrine showed significantly better lung function and lower inflammatory markers compared to those receiving tetrandrine alone.
Summary
This study tested whether adding hydrogen gas inhalation to a drug called tetrandrine could better treat silicosis (a lung disease caused by inhaling silica dust) compared to using tetrandrine alone. In 108 patients with stage II silicosis, those who received both hydrogen and tetrandrine showed better lung function, lower inflammation markers in their blood, and fewer breathing problems than those who received tetrandrine only.
Practical Takeaway
This early human study suggests that hydrogen inhalation combined with tetrandrine may help improve lung function in silicosis patients more effectively than tetrandrine alone. However, the study was relatively small and conducted in one hospital, so larger and longer-term studies would be needed to confirm these findings and determine if this approach could be useful for other populations with lung disease.
Abstract (excerpt)
Objective: This study aimed to evaluate the efficacy of tetrandrine (Tet) alone and in combination with hydrogen (H2) inhalation in patients with stage II silicosis. Methods: In this prospective, randomized, double-blind, controlled study, 116 patients with stage II silicosis treated at Lai Zhou…